Notable Labs, Ltd. (OTCPK: NTBL.Q)
Health Care · Biotechnology · US
$0.00
— today · -99.5% 1Y
Notable Labs, Ltd. (OTCPK: NTBL.Q) operates in the Biotechnology industry within the Health Care sector. The company is valued at $10.00 and employs 16 people.
Over the last twelve months the share price has lost 99.5%, trading between 0.00 and 0.00.
Tweenvest scores Notable Labs, Ltd. across four factors: quality 28/100, value 44/100. Its strongest factor is value.
NTBL.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.00
- Revenue (TTM)
- $313.00K
- P/E
- —
- EPS
- -1.42
- Dividend yield
- —
- Beta (5Y)
- 30.71
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.66M
- Employees
- 16
- Next earnings
- —
About Notable Labs, Ltd.
Notable Labs, Ltd., a clinical-stage platform therapeutics company, engages in developing predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient is likely to respond to that specific therapeutic. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and thus fast-track clinical development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor for acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes indications; and Fosciclopirox, a pro-drug of ciclopirox for AML. Notable Labs, Ltd. is headquartered in Foster City, California.
- Listed since
- Oct 1, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €884.60 | -1.93% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.